Improving early diagnosis of Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is a chronic autoimmune disease that affects 18 million people worldwide. It is a permanent condition that causes pain, swelling and stiffness in the joints. Early diagnosis and management can reduce symptoms, slow the disease progression and prevent disability. In some cases, the disease can go into remission (WHO).

  • Growing disease – one of the most common auto-immune diseases

  • Early diagnoses – significant impact on progression of the disease

  • Rapid RA test – new point-of-care test by Novio Catalpa

One of the most specific markers for diagnosing RA is the presence of anti-citrullinated protein antibodies (ACPA) in the blood. Currently, most tests for detecting these antibodies are complex and require sophisticated laboratory equipment. Novio Catalpa together with researchers at Radboud University have developed a new test that will change that.

Learn about our rapid RA test

Our test

Novio Catalpa has developed a completely new test to diagnose Rheumatoid Arthritis.

Our story

We are a team of seasoned professionels combining science and business

Discover The Future

We are a multi-disciplinary research company committed to

intelligent and efficient diagnostics

Contact Us